VIVUS Inc. (VVUS) in Focus: Stock Up 6% - Tale of the Tape - ANI Pharmaceuticals (NASDAQ:ANIP), Gilead Sciences (NASDAQ:GILD)

VIVUS Inc. VVUS was a big mover last session, as the company saw its shares rally 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, trading in a volatile price range of $4.59 to $5.57 in the past one-month time frame, showed a pick-up yesterday at $4.95.

The company has seen 6 positive estimate revisions in the past month, while its Zacks Consensus Estimate pegged at a loss narrowed over the same period, suggesting that more solid trading could be ahead for VIVUS. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.

VIVUS currently has a Zacks Rank #2 (Buy) while its Earnings ESP is negative.

Other attractive players in the healthcare industry include Gilead Sciences Inc. GILD, Myriad Genetics Inc. MYGN and ANI Pharmaceuticals, Inc. ANIP, all carrying a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.

Click to get this free report

ANI PHARMACEUT ANIP: Free Stock Analysis Report

GILEAD SCIENCES GILD: Free Stock Analysis Report

MYRIAD GENETICS MYGN: Free Stock Analysis Report

VIVUS INC VVUS: Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

Market News and Data brought to you by Benzinga APIs